Anchoring Intermittent Long Acting Antimicrobials to Medication for Opioid Use Disorder Treatment to Facilitate Structured Transitions of Care for People Who Use Drugs Admitted to the Hospital With Invasive Infections
Latest Information Update: 04 Jun 2025
At a glance
- Drugs Oritavancin (Primary)
- Indications Bacteraemia; Infectious arthritis; Osteomyelitis; Skin and soft tissue infections
- Focus Therapeutic Use
- Acronyms AIM-STOP
Most Recent Events
- 29 May 2025 Status changed from recruiting to discontinued as the study was not able to enroll adequate participants within predetermined timelines
- 09 Jul 2024 Planned End Date changed from 1 May 2025 to 31 Dec 2025.
- 09 Jul 2024 Planned primary completion date changed from 1 Mar 2025 to 30 Jun 2025.